I agree that this site is using cookies. You can find further informations here.
X
Tornieporth, Nadia
33  results:
Search for persons X
?
1

Meeting report: CEPI consultation on accelerating access to..:

Voss, Gerald ; Jacquet, Jeanne-Marie ; Tornieporth, Nadia...
Vaccine.  39 (2021)  51 - p. 7357-7362 , 2021
Link: https://doi.org/10.1016/..
 
?
2

A descriptive cross-sectional study of cholera at Kakuma an..:

Kisera, Nereah ; Luxemburger, Christine ; Tornieporth, Nadia..
Pan African Medical Journal.  37 (2020)  - p. , 2020
Link: https://doi.org/10.11604..
 
?
3

A review of Lassa fever vaccine candidates:

Salami, Kolawole ; Gouglas, Dimitrios ; Schmaljohn, Connie..
Current Opinion in Virology.  37 (2019)  - p. 105-111 , 2019
Link: https://doi.org/10.1016/..
 
?
4

Sequential Phase 1 and Phase 2 randomized, controlled trial..:

Kester, Kent E. ; Gray Heppner Jr, D. ; Moris, Philippe...
Vaccine.  32 (2014)  49 - p. 6683-6691 , 2014
Link: https://doi.org/10.1016/..
 
?
5

Comparison of the immunogenicity and safety of a split-viri..:

Frenck Jr., Robert W. ; Belshe, Robert ; Brady, Rebecca C....
Vaccine.  29 (2011)  34 - p. 5666-5674 , 2011
Link: https://doi.org/10.1016/..
 
?
6

Randomized, Double‐Blind Controlled Phase 3 Trial Comparing..:

Falsey, Ann R. ; Treanor, John J. ; Tornieporth, Nadia..
The Journal of Infectious Diseases.  200 (2009)  2 - p. 172-180 , 2009
Link: https://doi.org/10.1086/..
 
?
7

Randomized, Double-Blind Controlled Phase 3 Trial Comparing..:

Falsey, Ann R. ; Treanor, John J. ; Tornieporth, Nadia..
The Journal of Infectious Diseases.  200 (2009)  2 - p. 172-180 , 2009
Link: https://www.jstor.org/st..
 
?
8

Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day im..:

Kester, Kent E. ; Cummings, James F. ; Ockenhouse, Christian F....
Vaccine.  26 (2008)  18 - p. 2191-2202 , 2008
Link: https://doi.org/10.1016/..
 
?
9

A phase I/IIa safety, immunogenicity, and efficacy bridging..:

Kester, Kent E. ; McKinney, Denise A. ; Tornieporth, Nadia...
Vaccine.  25 (2007)  29 - p. 5359-5366 , 2007
Link: https://doi.org/10.1016/..
 
?
10

Epidemiology of Travelers- Diarrhea: Details of a Global Su..:

Steffen, Robert ; Tornieporth, Nadia ; Costa Clemens, Sue-Ann...
Journal of Travel Medicine.  11 (2006)  4 - p. 231-238 , 2006
Link: https://doi.org/10.2310/..
 
?
11

Safety and immunogenicty of RTS,S/AS02A candidate malaria v..:

Bojang, Kalifa A. ; Olodude, Folasade ; Pinder, Margaret...
Vaccine.  23 (2005)  32 - p. 4148-4157 , 2005
Link: https://doi.org/10.1016/..
 
?
12

Safety, tolerability, and antibody responses in humans afte..:

Epstein, Judith E ; Charoenvit, Yupin ; Kester, Kent E...
Vaccine.  22 (2004)  13-14 - p. 1592-1603 , 2004
Link: https://doi.org/10.1016/..
 
?
13

A CD4+ T-cell immune response to a conserved epitope in the..:

Reece, William H H ; Pinder, Margaret ; Gothard, Philip K...
Nature Medicine.  10 (2004)  4 - p. 406-410 , 2004
Link: https://doi.org/10.1038/..
 
?
14

Anamnestic response to administration of purified non-adsor..:

Dentico, Pietro ; Crovari, Pietro ; Lai, Piero Luigi...
Vaccine.  20 (2002)  31-32 - p. 3725-3730 , 2002
Link: https://doi.org/10.1016/..
 
?
15

Prevalence of Enteric Pathogens among International Travele..:

Jiang, Zhi-Dong ; Lowe, Brett ; Verenkar, M. P....
The Journal of Infectious Diseases.  185 (2002)  4 - p. 497-502 , 2002
Link: https://www.jstor.org/st..
 
1-15